Sai Agash Surendran

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Deutsches Konsortium für Translationale Krebsforschung(Current)

German Cancer Research Center

Ludwig-Maximilians-Universität München

Sai Agash Surendran is an author at Deutsches Konsortium für Translationale Krebsforschung specializing in molecular oncology, oncology, and medicine.

Publications per year

2022–2024

Publications

PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil

Leah Schöckel, Christine Woischke, Sai Agash Surendran et al. · BMC Cancer · 2024 · 26 citations · Full text

Medicine, Oncology, Pharmacology +16

TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer

Michael Guenther, Sai Agash Surendran, Michael Haas et al. · British Journal of Cancer · 2023 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer

Michael Guenther, Lina Gil, Sai Agash Surendran et al. · JNCI Cancer Spectrum · 2022 · 11 citations · Full text

Medicine, Microbiology, Oncology +17

1–3 of 3